Analyzing the Latest Data for Gonadotropin-Releasing Hormone Agonists and Antagonists in Prostate Cancer: What Does This Mean for the Patient?

Why does it really matter which GnRH agonist or antagonist you choose for your patient, and how can you use the latest data to inform this decision?

Credit available for this activity expires: 3/15/25 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1000411?ecd=bdc_podcast_libsyn_mscpedu